Role evidence
Usage summary
Strongest role: Inclusion Required
Inclusion-required count: 4
Treatment-assignment count: 0
Stratification count: 0
Manual Review Required
PD-L1 expression
breast cancer · Therapy Not Normalized
PD-L1 expression is flagged as manual review required because public trials show inclusion required evidence in 12 contexts. FDA CDx context exists.
Threshold snippets
Fragmentation view
Threshold count: 1
Common snippets: HER2-low
Threshold label: Low
FDA CDx context
Mapping summary
CDx label: Fda Cdx Context Exists
CDx maturity score: 5/5
Confidence: Low
Patent-density signal
Diagnostic appendix
Signal count: 1
Recent signals: 1
Density label: Low
Source links
Evidence paths
https://clinicaltrials.gov/study/NCT03459781 | https://clinicaltrials.gov/study/NCT05955105 | https://clinicaltrials.gov/study/NCT03206203 | https://clinicaltrials.gov/study/NCT05769010 | https://clinicaltrials.gov/study/NCT03007992 | https://clinicaltrials.gov/study/NCT01898117 | https://clinicaltrials.gov/study/NCT02221999 | https://clinicaltrials.gov/study/NCT04657237 | https://clinicaltrials.gov/study/NCT04770272 | https://clinicaltrials.gov/study/NCT03606967 | https://clinicaltrials.gov/study/NCT04802876 | https://clinicaltrials.gov/study/NCT03012100